Charles E. Argoff, MD, FABPM
Samuel Belok, MD
Andrew E. Budson, MD
Amy Clouse, MD, FAAFP
Oscar A. de Leon-Casasola, MD
Lisa M. Ferreira, MD, FOMA, DABOM, DABL
Katherine E. Galluzzi, DO, CMD, FACOFP
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Jennifer B. Green, MD
Stephen N. Henry, DO, MS
Jonette Keri, MD, PhD
Pamela Kushner, MD, FAAFP
Peter Lin, MD, CCFP
Vani Potluri, MD, DABOM
Charles Vega, MD, FAAFP
Shirah Vollmer, MD
Karol E. Watson, MD, PhD
Disclosures
The following financial relationships have been disclosed by faculty, and all relevant relationships have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- Researcher: AbbVie; Speaker: AbbVie, Averitas Pharma, Eli Lilly, Impel Pharmaceuticals, Kowa Pharmaceuticals, Lundbeck, Nevro Corporation, Scilex Pharmaceuticals, Teva Pharmaceuticals; Consultant: Collegium Pharmaceutical, Nevro Corporation, Pain Scripts, Scilex Pharmaceuticals, Shiratronics, Tris Pharma, Vertamical, Vertex Pharmaceuticals, and Xgene Pharma; Other: Lundbeck and Teva Pharmaceuticals; Stock Holder (publicly traded company): Pfizer and Trevena
- Samuel Belok, MD
- No relevant financial relationships disclosed
- Andrew E. Budson, MD
- Advisor: AbbVie, Eli Lilly; Consultant: Eli Lilly; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
- Amy Clouse, MD, FAAFP
- Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
- Oscar A. de Leon-Casasola, MD
- No relevant financial relationships disclosed.
- Lisa M. Ferreira, MD, FOMA, DABOM, DABL
- Speaker: Eli Lilly and Novo Nordisk Inc.
- Katherine E. Galluzzi, DO, CMD, FACOFP
- Advisor: Eli Lilly
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Consultant: OptumRx
- Jennifer B. Green, MD
- Consultant: Anji, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, Valo, Vertex, Vertex; Researcher: Bluedrop, Boehringer Ingelheim, Merck, Roche
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Jonette Keri, MD, PhD
- Advisor: Almirall; Advisor: Sanofi
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
- Vani Potluri, MD, DABOM
- No relevant financial relationships disclosed.
- Charles Vega, MD, FAAFP
- Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
- Shirah Vollmer, MD
- No relevant financial relationships disclosed.
- Karol E. Watson, MD, PhD
- Consultant: Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Regeneron
Other Disclosures
All relevant relationships have been mitigated by Pri-Med Institute. All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.